A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial

A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial

Abstract Background The most appropriate anti-inflammatory treatment for moderate COVID-19 pneumonia remains uncertain. We aimed to compare the effectiveness of a high-dose methylprednisolone versus a high-dose dexamethasone in hospitalized moderate COVID-19 pneumonia, regarding the WHO clinical pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jakkrit Laikitmongkhon, Tanapat Tassaneyasin, Yuda Sutherasan, Angsana Phuphuakrat, Sirawat Srichatrapimuk, Tananchai Petnak, Dararat Eksombatchai, Kanin Thammavaranucupt, Somnuek Sungkanuparph
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Pulmonary Medicine
Subjects:
COVID-19
Moderate pneumonia
Corticosteroids
Randomized controlled trial
Online Access:https://doi.org/10.1186/s12890-024-03364-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12890-024-03364-4

Similar Items